missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ ZNF9 Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA566556
This item is not returnable.
View return policy
Description
Immunogen sequence: GMRSRGRGGFT SDRGFQFVSS SLPDICYRCG ESG Highest antigen sequence identity to the following orthologs - mouse 100%, rat 100%.
This gene encodes a nucleic-acid binding protein with seven zinc-finger domains. The protein has a preference for binding single stranded DNA and RNA. The protein functions in cap-independent translation of ornithine decarboxylase mRNA, and may also function in sterol-mediated transcriptional regulation. A CCTG expansion in the first intron of this gene results in myotonic dystrophy type 2. Multiple transcript variants encoding different isoforms have been found for this gene.
Specifications
| ZNF9 | |
| Polyclonal | |
| Unconjugated | |
| CNBP | |
| AA408710; CCHC-type zinc finger nucleic acid binding protein; CCHC-type zinc finger, nucleic acid binding protein; cellular nucleic acid binding protein; cellular nucleic acid binding protein 1; cellular nucleic acid-binding protein; CNBP; CNBP1; DM2; erythroid differentiation-related; HGNC:13164; PROMM; RNF163; sterol regulatory element-binding protein; ZCCHC22; zinc finger protein 273; zinc finger protein 9; zinc finger protein 9 (a cellular retroviral nucleic acid binding protein); Znf9 | |
| Rabbit | |
| Antigen Affinity Chromatography | |
| RUO | |
| 7555 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 0.1 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| P62633 | |
| CNBP | |
| Recombinant Human ZNF9. Recombinant protein control fragment (Product #RP-105254). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction